04:30 PM EDT, 06/05/2025 (MT Newswires) -- Percy H. Carter, Chief Scientific Officer, on June 03, 2025, sold 2,659 shares in Blueprint Medicines ( BPMC ) for $340,033. Following the Form 4 filing with the SEC, Carter has control over a total of 54,206 common shares of the company, with 54,206 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1597264/000141588925015767/xslF345X05/form4-06052025_040601.xml